You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series

Article metrics

Article menu

Download PDFPDF

XML
Case Report
Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series

 

Online download statistics by month:

Online download statistics by month: December 2019 to August 2025

AbstractFullPdf
Dec 2019110
Jan 202020200
Feb 202013131
Mar 202016162
Apr 2020992
May 202030305
Jun 202022222
Jul 202012126
Aug 2020993
Sep 202017172
Oct 202030304
Nov 202025258
Dec 202021215
Jan 202116165
Feb 202110107
Mar 2021161611
Apr 2021111111
May 2021887
Jun 2021232311
Jul 202113137
Aug 2021556
Sep 2021131310
Oct 2021323229
Nov 2021141515
Dec 202116165
Jan 202212147
Feb 202211117
Mar 2022993
Apr 202220204
May 2022212117
Jun 2022252714
Jul 202212146
Aug 2022131410
Sep 2022242434
Oct 202213156
Nov 202210115
Dec 202216166
Jan 2023161611
Feb 202314156
Mar 2023444525
Apr 2023121317
May 2023888
Jun 202315154
Jul 2023131311
Aug 2023885
Sep 20239105
Oct 2023171712
Nov 2023774
Dec 202321217
Jan 2024887
Feb 2024141410
Mar 2024101010
Apr 2024101010
May 2024171813
Jun 2024181811
Jul 2024313175
Aug 2024141516
Sep 2024111170
Oct 20241212129
Nov 202418198
Dec 202413136
Jan 2025283223
Feb 2025788016
Mar 2025171716
Apr 2025282812
May 2025242425
Jun 202591015
Jul 2025110
Aug 2025110
Total11341159870